|
ARCT Arcturus Therapeutics Holdings Inc 1768224 |
| Balance Sheet |
|
Current Assets
|
$216,882,000.00 |
|
Assets
|
$245,411,000.00 |
|
Current Liabilities
|
$34,369,000.00 |
|
Liabilities
|
$54,049,000.00 |
|
Equity
|
$191,362,000.00 |
|
Shares Out
|
28423000.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-19,441,000.00 |
|
Investing Cash Flow
|
$34,000.00 |
| Market Analysis |
Market Cap
|
$168,264,160.00 |
|
Price
|
$5.83 |
|
BVPS
|
6.73 |
|
PB
|
0.88 |
|
EPS
|
-0.95 |
|
PS
|
25.10 |
|
FCF
|
$-19,441,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:34 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:32 |
| Apr |
May |
Jun |
| 2026-03-03 |
-1.03 |
|
|
2026-05-07 |
-0.95 |
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-11 |
-0.34 |
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-10 |
-0.49 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ARCT documents filed with the SEC.
ARCT Filings
Clear